Traws Pharma, Inc. — Director's Dealing 2013

Aug 2, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-25

Reporting Person: Reddy E Premkumar (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-25	Common Stock	P	300	$22.71	Acquired	1273018	Direct
2013-07-25	Common Stock	P	700	$22.73	Acquired	1273718	Direct

Footnotes

F1: Shares held jointly with spouse.